TickerFactsScreenerDevelopers

SANGAMO THERAPEUTICS, INC (SGMO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$6.14M2010: -$23.93M2011: -$25.89M2012: -$8.08M2013: -$19.48M2016: -$65.88M2017: $11.18M2018: $36.55M2019: -$144.40M2020: $169.88M2021: -$233.25M2022: -$223.63M2023: -$224.84M2024: -$67.14M2025: -$97.21M-$97.21M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$97.21M-44.8%
2024-$67.14M+70.1%
2023-$224.84M-0.5%
2022-$223.63M+4.1%
2021-$233.25M-237.3%
2020$169.88M+217.6%
2019-$144.40M-495.1%
2018$36.55M+227.0%
2017$11.18M+117.0%
2016-$65.88M—
2013-$19.48M-141.1%
2012-$8.08M+68.8%
2011-$25.89M-8.2%
2010-$23.93M-290.0%
2009-$6.14M—